TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway
Objective: Obesity and type 2 diabetes (T2D) lead to various life-threatening diseases such as coronary heart disease, stroke, osteoarthritis, asthma, and neurodegeneration. Therefore, extensive research is ongoing to identify novel pathways that can be targeted in obesity/T2D. Deletion of the inosi...
Main Authors: | Sarbani Ghoshal, Qingzhang Zhu, Alice Asteian, Hua Lin, Haifei Xu, Glen Ernst, James C. Barrow, Baoji Xu, Michael D. Cameron, Theodore M. Kamenecka, Anutosh Chakraborty |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-10-01
|
Series: | Molecular Metabolism |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877816301259 |
Similar Items
-
Global IP6K1 deletion enhances temperature modulated energy expenditure which reduces carbohydrate and fat induced weight gain
by: Qingzhang Zhu, et al.
Published: (2017-01-01) -
N,4-Dimethyl-N-(4-nitrobenzyl)benzenesulfonamide
by: Shende Jiang, et al.
Published: (2008-03-01) -
Whole Body <i>Ip6k1</i> Deletion Protects Mice from Age-Induced Weight Gain, Insulin Resistance and Metabolic Dysfunction
by: Sarbani Ghoshal, et al.
Published: (2022-02-01) -
TNP o TPAN
by: Daniel Lahoz Casas
Published: (2023-01-01) -
2-Chloro-9-isopropyl-N,N-dimethyl-9H-purin-6-amine
by: Michal Rouchal, et al.
Published: (2010-05-01)